Zobrazeno 1 - 10
of 52
pro vyhledávání: '"E. LEFTHERIOTIS"'
Publikováno v:
Archives of Razi Institute, Vol 22, Iss 1, Pp 19-34 (1970)
Externí odkaz:
https://doaj.org/article/bc35769790444003959f527553cff626
Introduction: Nonrandomized studies suggest a survival benefit for patients with atrial fibrillation (AF) undergoing catheter ablation compared with antiarrhythmic drug (AAD) therapy. Data from randomized trials are lacking. We performed a meta-analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::5cd16402f6479de8324c4cf57edc2b06
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3131219
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3131219
Publikováno v:
Bulletin de l'Académie Vétérinaire de France. 110:307-314
Mackowiak Czesław, Leftheriotis E., Camand R., Goret Pierre. Recherches expérimentales sur la Souche S. F. A. du virus suipestique lapinisé . In: Bulletin de l'Académie Vétérinaire de France tome 110 n°7, 1957. pp. 307-314.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e6df676774de4b5ba573740af60a1b
https://doi.org/10.4267/2042/68063
https://doi.org/10.4267/2042/68063
Publikováno v:
Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc. 1
Vaccinia melanoma oncolysates (VMO) were tested in a Southeastern Cancer Study Group (SECSG)-sponsored phase I/II multiinstitutional trial. Forty-eight patients with stage I or II disease were placed on study at six different dose levels of VMO and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::41129a3e47c8fa8de035999ebfe1f04b
https://pubmed.ncbi.nlm.nih.gov/3155379
https://pubmed.ncbi.nlm.nih.gov/3155379
Publikováno v:
Journal of biological response modifiers. 2(6)
A preliminary trial was designed as a toxicity/feasibility study using a fixed dose of vaccinia melanoma oncolysates (VMO) to treat recurrent stage II and stage III (skin, subcutaneous, and nodal metastases only) melanoma. There were no adverse conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc22f470c90e4a65d909ae50be7e451d
https://pubmed.ncbi.nlm.nih.gov/6663322
https://pubmed.ncbi.nlm.nih.gov/6663322
Autor:
M K, Wallack, K R, McNally, E, Leftheriotis, H, Seigler, C, Balch, H, Wanebo, A A, Bartolucci, J A, Bash
Publikováno v:
Cancer. 57(3)
Vaccinia melanoma oncolysates (VMO) were tested in a Southeastern Cancer Study Group (SECSG) Phase I/II trial. Forty-eight patients with high-risk Stage I or pathologic Stage II disease were placed on study at six different dose levels and two differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b249e545140ea406b8ee908e18dc9d3
https://pubmed.ncbi.nlm.nih.gov/3943002
https://pubmed.ncbi.nlm.nih.gov/3943002
Autor:
P, Noël, M, Faucon, E, Leftheriotis, B, Fontanière, C, Bailly, C, Carcagne, M, Groleas, M, Rezvoy
Publikováno v:
Annales d'anatomie pathologique. 24(2)
The culture of human cutaneous malignant melanomas is an important stage in the preparation of oncolysates for therapeutic purposes. The authors recall the definition of oncolysate: lysis of the malignant melanocyte by vaccinia virus liberates masked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0ea80f8023e47ecdd34c0f508cd5552
https://pubmed.ncbi.nlm.nih.gov/525843
https://pubmed.ncbi.nlm.nih.gov/525843
Publikováno v:
Pathologie et biologie. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::235dd4d9493ade96b577a0fd4b0c80ec
https://pubmed.ncbi.nlm.nih.gov/13958604
https://pubmed.ncbi.nlm.nih.gov/13958604
Publikováno v:
Annales de l'Institut Pasteur. 122(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7e2540848018e67e965446aaf4e2194
https://pubmed.ncbi.nlm.nih.gov/5051236
https://pubmed.ncbi.nlm.nih.gov/5051236
Publikováno v:
Comptes rendus hebdomadaires des seances de l'Academie des sciences. 253
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a5c692f0100bb14b57356ecf6297937
https://pubmed.ncbi.nlm.nih.gov/13893921
https://pubmed.ncbi.nlm.nih.gov/13893921